Loading…
Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients
In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 ye...
Saved in:
Published in: | PloS one 2013-10, Vol.8 (10), p.e78100-e78100 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3 |
---|---|
cites | cdi_FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3 |
container_end_page | e78100 |
container_issue | 10 |
container_start_page | e78100 |
container_title | PloS one |
container_volume | 8 |
creator | van Overbeek, Ellen C Staals, Julie van Oostenbrugge, Robert J |
description | In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation. |
doi_str_mv | 10.1371/journal.pone.0078100 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1441864689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478272560</galeid><doaj_id>oai_doaj_org_article_b4bbbeddc72a4afe816a1e0887e02844</doaj_id><sourcerecordid>A478272560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3</originalsourceid><addsrcrecordid>eNqNk0tv1DAQxyMEomXhGyCwhITgkMWvOMkFaal4rFSpEo9eLcdxdr04cWo7LfvtcbpptUE9IB9szfzmb894JkleIrhEJEcfdnZwnTDL3nZqCWFeIAgfJaeoJDhlGJLHR-eT5Jn3OwgzUjD2NDnBFGVZWZDTxF_qIFrdgU8IA9HVoHd245T32nbANuBmq4MCrQhBOWDUaPZLsAI43SvhQGONsTfp0AMfhnoPolCjnQ-puh55IYcuUj44-1uBXgStuuCfJ08aYbx6Me2L5NeXzz_PvqXnF1_XZ6vzVLISh5TKXBBJSyIoxiIvJSUZwRVhoslqSKsaN9EZCUYgrUuUUVlgBeuiJIg1VUMWyeuDbm-s51O9PEeUooJRFrlFsj4QtRU73jvdCrfnVmh-a7Buw4ULWhrFK1pVlaprmWNBRaMKxARSsChyBXFBadT6ON02VK2qZczUCTMTnXs6veUbe81JXjKajY95Nwk4ezUoH3irvVTGiE7Z4fbdWYkwYkVE3_yDPpzdRG1ETEB3jY33ylGUr2he4BxnDEZq-QAVV61aLWNzNTraZwHvZwGRCepP2IjBe77-8f3_2YvLOfv2iN0qYcLWWzOEsefmID2A0lnvnWrui4wgH2fjrhp8nA0-zUYMe3X8QfdBd8NA_gK3XQk6</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1441864689</pqid></control><display><type>article</type><title>Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>van Overbeek, Ellen C ; Staals, Julie ; van Oostenbrugge, Robert J</creator><contributor>Baron, Jean-Claude</contributor><creatorcontrib>van Overbeek, Ellen C ; Staals, Julie ; van Oostenbrugge, Robert J ; Baron, Jean-Claude</creatorcontrib><description>In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0078100</identifier><identifier>PMID: 24155983</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Aged ; Blood-brain barrier ; Brain ; Brain - pathology ; Brain research ; Cerebral Ventricles - pathology ; Cyanocobalamin ; Diabetes ; Disease Progression ; Family medical history ; Female ; Follow-Up Studies ; Homocysteine ; Humans ; Hypertension ; Lesions ; Logistic Models ; Magnetic resonance imaging ; Male ; Medical research ; Middle Aged ; Neurology ; NMR ; Nuclear magnetic resonance ; Patients ; Plasma levels ; Prevention ; Regression analysis ; Statistical analysis ; Stroke ; Stroke patients ; Stroke, Lacunar - blood ; Stroke, Lacunar - pathology ; Substantia alba ; Supplementation ; Supplements ; Vitamin B 12 - blood ; Vitamin B12 ; Vitamin deficiency ; Vitamins</subject><ispartof>PloS one, 2013-10, Vol.8 (10), p.e78100-e78100</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 van Overbeek et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 van Overbeek et al 2013 van Overbeek et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3</citedby><cites>FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1441864689/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1441864689?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24155983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Baron, Jean-Claude</contributor><creatorcontrib>van Overbeek, Ellen C</creatorcontrib><creatorcontrib>Staals, Julie</creatorcontrib><creatorcontrib>van Oostenbrugge, Robert J</creatorcontrib><title>Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation.</description><subject>Age</subject><subject>Aged</subject><subject>Blood-brain barrier</subject><subject>Brain</subject><subject>Brain - pathology</subject><subject>Brain research</subject><subject>Cerebral Ventricles - pathology</subject><subject>Cyanocobalamin</subject><subject>Diabetes</subject><subject>Disease Progression</subject><subject>Family medical history</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Lesions</subject><subject>Logistic Models</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Patients</subject><subject>Plasma levels</subject><subject>Prevention</subject><subject>Regression analysis</subject><subject>Statistical analysis</subject><subject>Stroke</subject><subject>Stroke patients</subject><subject>Stroke, Lacunar - blood</subject><subject>Stroke, Lacunar - pathology</subject><subject>Substantia alba</subject><subject>Supplementation</subject><subject>Supplements</subject><subject>Vitamin B 12 - blood</subject><subject>Vitamin B12</subject><subject>Vitamin deficiency</subject><subject>Vitamins</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk0tv1DAQxyMEomXhGyCwhITgkMWvOMkFaal4rFSpEo9eLcdxdr04cWo7LfvtcbpptUE9IB9szfzmb894JkleIrhEJEcfdnZwnTDL3nZqCWFeIAgfJaeoJDhlGJLHR-eT5Jn3OwgzUjD2NDnBFGVZWZDTxF_qIFrdgU8IA9HVoHd245T32nbANuBmq4MCrQhBOWDUaPZLsAI43SvhQGONsTfp0AMfhnoPolCjnQ-puh55IYcuUj44-1uBXgStuuCfJ08aYbx6Me2L5NeXzz_PvqXnF1_XZ6vzVLISh5TKXBBJSyIoxiIvJSUZwRVhoslqSKsaN9EZCUYgrUuUUVlgBeuiJIg1VUMWyeuDbm-s51O9PEeUooJRFrlFsj4QtRU73jvdCrfnVmh-a7Buw4ULWhrFK1pVlaprmWNBRaMKxARSsChyBXFBadT6ON02VK2qZczUCTMTnXs6veUbe81JXjKajY95Nwk4ezUoH3irvVTGiE7Z4fbdWYkwYkVE3_yDPpzdRG1ETEB3jY33ylGUr2he4BxnDEZq-QAVV61aLWNzNTraZwHvZwGRCepP2IjBe77-8f3_2YvLOfv2iN0qYcLWWzOEsefmID2A0lnvnWrui4wgH2fjrhp8nA0-zUYMe3X8QfdBd8NA_gK3XQk6</recordid><startdate>20131014</startdate><enddate>20131014</enddate><creator>van Overbeek, Ellen C</creator><creator>Staals, Julie</creator><creator>van Oostenbrugge, Robert J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20131014</creationdate><title>Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients</title><author>van Overbeek, Ellen C ; Staals, Julie ; van Oostenbrugge, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age</topic><topic>Aged</topic><topic>Blood-brain barrier</topic><topic>Brain</topic><topic>Brain - pathology</topic><topic>Brain research</topic><topic>Cerebral Ventricles - pathology</topic><topic>Cyanocobalamin</topic><topic>Diabetes</topic><topic>Disease Progression</topic><topic>Family medical history</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Lesions</topic><topic>Logistic Models</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Patients</topic><topic>Plasma levels</topic><topic>Prevention</topic><topic>Regression analysis</topic><topic>Statistical analysis</topic><topic>Stroke</topic><topic>Stroke patients</topic><topic>Stroke, Lacunar - blood</topic><topic>Stroke, Lacunar - pathology</topic><topic>Substantia alba</topic><topic>Supplementation</topic><topic>Supplements</topic><topic>Vitamin B 12 - blood</topic><topic>Vitamin B12</topic><topic>Vitamin deficiency</topic><topic>Vitamins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Overbeek, Ellen C</creatorcontrib><creatorcontrib>Staals, Julie</creatorcontrib><creatorcontrib>van Oostenbrugge, Robert J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Overbeek, Ellen C</au><au>Staals, Julie</au><au>van Oostenbrugge, Robert J</au><au>Baron, Jean-Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-10-14</date><risdate>2013</risdate><volume>8</volume><issue>10</issue><spage>e78100</spage><epage>e78100</epage><pages>e78100-e78100</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>In cross-sectional studies periventricular white matter lesions (WML) were related to low plasma levels of vitamin B12. Whether low vitamin B12 levels are also related to progression of WML is still unknown. We studied baseline vitamin B12 levels and its association with progression of WML over 2 years of follow-up in first-ever lacunar stroke patients. In 107 first-ever lacunar stroke patients in whom baseline brain MRI and vitamin B12 status were available, we obtained a follow-up brain MRI after 2 years. We assessed progression of periventricular WML (pWML) and deep WML (dWML) using a visual WML change scale. We studied the relationship between baseline levels of plasma vitamin B12 and progression of WML after 2 years of follow-up by binary logistic regression analyses. Vitamin B12 deficiency was more frequent in patients with progression of pWML compared to those without progression (41.9% and 19.7% respectively, p = 0.02). Corrected for sex and age, progression of pWML was associated with lower baseline levels of vitamin B12 (OR 1.42 per 50 unit decrease, 95% CI 1.00-1.92). Vitamin B12 levels were not associated with progression of dWML. In conclusion progression of pWML after 2 years of follow-up relates to low levels of vitamin B12 at baseline in first-ever lacunar stroke patients. Whether this population could benefit from vitamin B12 supplementation is unknown and requires further investigation.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24155983</pmid><doi>10.1371/journal.pone.0078100</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2013-10, Vol.8 (10), p.e78100-e78100 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1441864689 |
source | Publicly Available Content Database; PubMed Central |
subjects | Age Aged Blood-brain barrier Brain Brain - pathology Brain research Cerebral Ventricles - pathology Cyanocobalamin Diabetes Disease Progression Family medical history Female Follow-Up Studies Homocysteine Humans Hypertension Lesions Logistic Models Magnetic resonance imaging Male Medical research Middle Aged Neurology NMR Nuclear magnetic resonance Patients Plasma levels Prevention Regression analysis Statistical analysis Stroke Stroke patients Stroke, Lacunar - blood Stroke, Lacunar - pathology Substantia alba Supplementation Supplements Vitamin B 12 - blood Vitamin B12 Vitamin deficiency Vitamins |
title | Vitamin B12 and progression of white matter lesions. A 2-year follow-up study in first-ever lacunar stroke patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A27%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20B12%20and%20progression%20of%20white%20matter%20lesions.%20A%202-year%20follow-up%20study%20in%20first-ever%20lacunar%20stroke%20patients&rft.jtitle=PloS%20one&rft.au=van%20Overbeek,%20Ellen%20C&rft.date=2013-10-14&rft.volume=8&rft.issue=10&rft.spage=e78100&rft.epage=e78100&rft.pages=e78100-e78100&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0078100&rft_dat=%3Cgale_plos_%3EA478272560%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-4c7a3c493a422a79c43532b36af5d04bd2f4933c46304d9154c82e0d89316fbf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1441864689&rft_id=info:pmid/24155983&rft_galeid=A478272560&rfr_iscdi=true |